Evidence map›Paper›PMID 37445792›Full record

ArticleInternational journal of molecular sciences2023

Association of Low Serum Bilirubin Concentrations and Promoter Variations in the

Alena Jirásková, Jan Škrha, Libor Vítek

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in International journal of molecular sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 5 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Alena JiráskováInstitute of Medical Biochemistry and Laboratory Diagnostics, 1st Faculty of Medicine, Charles University, General University Hospital in Prague, Katerinska 32, 12000 Prague, Czech Republic.
Jan Škrha3rd Department of Internal Medicine, 1st Faculty of Medicine, Charles University, General University Hospital in Prague, Katerinska 32, 12000 Prague, Czech Republic.
Libor VítekInstitute of Medical Biochemistry and Laboratory Diagnostics, 1st Faculty of Medicine, Charles University, General University Hospital in Prague, Katerinska 32, 12000 Prague, Czech Republic.ORCID 0000-0002-5318-0151
Charles University · CZ

Funding

Charles University Cooperatio Program, research area DIAGEuropean Union EXCELES LX22NPO5104Ministry of Health MH CZ-DRO-VFN64165
6 · The paper itself

Abstract

Bilirubin has potent biological beneficial effects, protecting against atherosclerosis, obesity, and metabolic syndrome. The aim of this study was to assess serum bilirubin concentrations and (TA)

Indexed as

Diabetes Mellitus, Type 2Polymorphism, GeneticBilirubinCzech RepublicFemaleGenotypeGlucuronosyltransferaseHeme Oxygenase-1HumansMalePromoter Regions, GeneticBilirubinGlucuronosyltransferaseHeme Oxygenase-1HMOX1 protein, humanbenign hyperbilirubinemiabilirubinGilbert syndromeheme oxygenaseHMOX1type 2 diabetes mellitusUGT1A1

Identifiers

PMID37445792
PMCPMC10342136
OpenAlexW4382137999

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.